Ultragenyx
MEPSEVII
Manufacturer:
Ultragenyx
Name:
MEPSEVII
HCPCS Code Descriptor:
Injection, vestronidase alfa-vjbk, 1 mg
Category:
J Code
HCPCS:
J3397
NDC(s):
69794-0001-01
Primary Type:
Enzyme Replacement Therapy
Generic Status:
Single-Source
Route of Administration:
Intravenous
About:
MEPSEVII is an Enzyme Replacement Therapy drug manufactured by Ultragenyx and administered via the Intravenous route of administration. The J Code: J3397 is aligned to the drug MEPSEVII.
Access Pricing and More By Registering
HCPCS Added Date:
1/1/19
HCPCS Effective Date:
1/1/19
HCPCS Short Description:
Inj., vestronidase alfa-vjbk
Billing and Coding Guide:
https://www.mepsevii.com/hcp/patient-services-reimbursement/billing-and-coding/
Patient Assistance:
https://www.ultracaresupport.com/patient-services/